These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9612358)

  • 1. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure.
    Coker ML; Thomas CV; Clair MJ; Hendrick JW; Krombach RS; Galis ZS; Spinale FG
    Am J Physiol; 1998 May; 274(5):H1516-23. PubMed ID: 9612358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
    Spinale FG; Coker ML; Thomas CV; Walker JD; Mukherjee R; Hebbar L
    Circ Res; 1998 Mar; 82(4):482-95. PubMed ID: 9506709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.
    Spinale FG; Coker ML; Krombach SR; Mukherjee R; Hallak H; Houck WV; Clair MJ; Kribbs SB; Johnson LL; Peterson JT; Zile MR
    Circ Res; 1999 Aug; 85(4):364-76. PubMed ID: 10455065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
    Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
    J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.
    McElmurray JH; Mukherjee R; New RB; Sampson AC; King MK; Hendrick JW; Goldberg A; Peterson TJ; Hallak H; Zile MR; Spinale FG
    J Pharmacol Exp Ther; 1999 Nov; 291(2):799-811. PubMed ID: 10525103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases: regulation and dysregulation in the failing heart.
    Spinale FG
    Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial extracellular matrix remodeling with the development of pacing induced congestive heart failure contributory mechanisms.
    Coker ML; Spinale FG
    Cardiovasc Pathol; 1998; 7(3):161-8. PubMed ID: 25851223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches to retard ventricular remodeling in heart failure.
    Spinale FG
    Eur J Heart Fail; 1999 Mar; 1(1):17-23. PubMed ID: 10937974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.
    King MK; Coker ML; Goldberg A; McElmurray JH; Gunasinghe HR; Mukherjee R; Zile MR; O'Neill TP; Spinale FG
    Circ Res; 2003 Feb; 92(2):177-85. PubMed ID: 12574145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.
    Nagatomo Y; Carabello BA; Coker ML; McDermott PJ; Nemoto S; Hamawaki M; Spinale FG
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H151-61. PubMed ID: 10644594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure.
    Houck WV; Pan LC; Kribbs SB; Clair MJ; McDaniel GM; Krombach RS; Merritt WM; Pirie C; Iannini JP; Mukherjee R; Spinale FG
    Circulation; 1999 Nov; 100(19):2003-9. PubMed ID: 10556227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations.
    Coker ML; Doscher MA; Thomas CV; Galis ZS; Spinale FG
    Am J Physiol; 1999 Aug; 277(2):H777-87. PubMed ID: 10444506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
    Bradham WS; Moe G; Wendt KA; Scott AA; Konig A; Romanova M; Naik G; Spinale FG
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1288-95. PubMed ID: 11893563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure.
    Mukherjee R; Hewett KW; Walker JD; Basler CG; Spinale FG
    Cardiovasc Res; 1998 Feb; 37(2):432-44. PubMed ID: 9614498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.